Reply to: Prediction of benefit from chemotherapy in ER-positive/HER2-negative breast cancer

A. Goldhirsch, A. S. Coates

Research output: Contribution to journalArticle

1 Citation (Scopus)
Original languageEnglish
Article numbermdt596
Pages (from-to)755
Number of pages1
JournalAnnals of Oncology
Volume25
Issue number3
DOIs
Publication statusPublished - Mar 2014

ASJC Scopus subject areas

  • Oncology
  • Hematology

Cite this

Reply to : Prediction of benefit from chemotherapy in ER-positive/HER2-negative breast cancer. / Goldhirsch, A.; Coates, A. S.

In: Annals of Oncology, Vol. 25, No. 3, mdt596, 03.2014, p. 755.

Research output: Contribution to journalArticle

@article{0c2e11fe9489436795e16be68f0d5827,
title = "Reply to: Prediction of benefit from chemotherapy in ER-positive/HER2-negative breast cancer",
author = "A. Goldhirsch and Coates, {A. S.}",
year = "2014",
month = "3",
doi = "10.1093/annonc/mdt596",
language = "English",
volume = "25",
pages = "755",
journal = "Annals of Oncology",
issn = "0923-7534",
publisher = "NLM (Medline)",
number = "3",

}

TY - JOUR

T1 - Reply to

T2 - Prediction of benefit from chemotherapy in ER-positive/HER2-negative breast cancer

AU - Goldhirsch, A.

AU - Coates, A. S.

PY - 2014/3

Y1 - 2014/3

UR - http://www.scopus.com/inward/record.url?scp=84896889759&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84896889759&partnerID=8YFLogxK

U2 - 10.1093/annonc/mdt596

DO - 10.1093/annonc/mdt596

M3 - Article

C2 - 24458471

AN - SCOPUS:84896889759

VL - 25

SP - 755

JO - Annals of Oncology

JF - Annals of Oncology

SN - 0923-7534

IS - 3

M1 - mdt596

ER -